Lengauer, Christoph
Blueprint Medicines Corporation,
United States
2025 Rank: 24111
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 1061 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24111 | 28263 |
| Total Cites | 37138 | 38624 |
| H-index | 73 | 74 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 83 | 84 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 5908 | 6034 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 12181 | 12534 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 31285 | 32139 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.20 |
| Self-Citation Percentage |
3.85%
|
|
Lengauer, Christoph
Blueprint Medicines Corporation,
United States
2024 Rank: 22371
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 1009 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22371 | 26033 |
| Total Cites | 36035 | 37500 |
| H-index | 71 | 73 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 83 | 84 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 5819 | 5945 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 11885 | 12234 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 30285 | 31123 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.20 |
| Self-Citation Percentage |
3.91%
|
|
Lengauer, Christoph
The Sidney Kimmel Comprehensive Cancer Center,
United States
2023 Rank: 20509
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 938 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20509 | 24111 |
| Total Cites | 34943 | 36382 |
| H-index | 71 | 72 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 82 | 83 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 5735 | 5861 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 11587 | 11933 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 29272 | 30086 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.21 |
| Self-Citation Percentage |
3.96%
|
|
Lengauer, Christoph
Blueprint Medicines Corporation,
United States
2022 Rank: 18616
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 850 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18616 | 22206 |
| Total Cites | 33563 | 34965 |
| H-index | 69 | 71 |
| Hm-index | 18 | 18 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 82 | 83 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 5606 | 5732 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 11163 | 11503 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 28035 | 28825 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.21 |
| Self-Citation Percentage |
4.01%
|
|
Lengauer, Christoph
Third Rock Ventures,
United States
2021 Rank: 17879
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 811 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 17879 | 20906 |
| Total Cites | 32714 | 34104 |
| H-index | 69 | 71 |
| Hm-index | 18 | 18 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 81 | 82 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 5516 | 5642 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 10913 | 11249 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 27269 | 28051 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.22 |
| Self-Citation Percentage |
4.08%
|
|
Lengauer, Christoph
Blueprint Medicines Corporation,
United States
2020 Rank: 16140
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 779 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 16140 | 19011 |
| Total Cites | 31193 | 32546 |
| H-index | 67 | 68 |
| Hm-index | 18 | 18 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 81 | 82 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 5372 | 5503 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 10473 | 10804 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 25780 | 26531 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.23 |
| Self-Citation Percentage |
4.16%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.